WeVote

Bill

Bill

HB 9

AN ACT relating to regulated substances and declaring an emergency.

2026 Regular Session Introduced by Matt Koch and 2 co-sponsors

Kentucky HB 9 addresses regulated substances with an emergency declaration and committee amendments, advancing through Senate committees with unspecified policy changes.

floor amendments (1), (2) and (3) filed
0
WeVote Research Nonpartisan
Bill Summary · HB 9

Legislative bill overview

HB 9 is a Kentucky bill addressing regulated substances that has moved through the House with a committee substitute and is now in Senate consideration. The bill's specific provisions are not detailed in the legislative history provided, making it difficult to characterize its exact scope or intent.

Why is this important

Bills relating to regulated substances typically address drug policy, pharmaceutical controls, or related enforcement mechanisms—areas with significant public health and criminal justice implications. The "emergency" declaration suggests the sponsors view this as requiring expedited action.

Potential points of contention

  • Lack of transparency: Without knowing the bill's actual provisions, stakeholders and the public cannot meaningfully assess its merits or problems
  • Committee substitute changes: The favorable report with a committee substitute indicates substantive modifications were made, raising questions about what changed and whether original sponsors' intent was preserved
  • Regulated substances scope: Depending on whether this addresses opioids, controlled substances scheduling, hemp/cannabis, or other areas, it could generate significant disagreement across public health, law enforcement, and industry groups

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.